Pharmaceutical News and Articles

High-Puff Vapes Become More Toxic Over Time, Study Says

WEDNESDAY, June 3, 2026 E-cigarettes that offer a lot of extra puffs might become more toxic the longer they are used, a new study says.High-puff vapes can typi

Urine Test Can Detect Autism, Study Says

WEDNESDAY, June 3, 2026 A simple urine test might help identify children who are likely to have autism earlier than the best assessment tools now available, a n

Just 90 Minutes Of Strength Training A Week Linked To Longer Life

WEDNESDAY, June 3, 2026 A few sessions in the weight room each week could do more than build muscle they may help you live longer.While the evidence linking aer

Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE BMY) today announced that SystImmune s parent company, Sic

Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients with Advanced HR-Positive Breast Cancer with an Emergent ESR1 Tumor Mutation in SERENA-6 trial

Further positive results from the Phase III SERENA-6 trial showed AstraZeneca s camizestrant plus a cyclin-dependent kinase (CDK) 4 6 inhibitor palbociclib, rib

FDA Approves Label Expansion, Cementing Tremfya as the Only IL‑23 Inhibitor Proven to Help Stop Further Joint Damage

ATS: Early Nonadherence to CPAP Does Not Predict Treatment Abandonment

For adults with obstructive sleep apnea (OSA), early nonadherence to continuous positive airway pressure (CPAP) does not predict treatment abandonment, accordin

Over One-Third of U.S. Adults Report More Than One Sunburn in Previous 12 Months

More than one-third of U.S. adults report at least one sunburn during the previous 12 months, according to research published in the May 21 issue of the U.S. Ce

Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check

TUESDAY, June 2, 2026 A recently approved asthma drug can help those with asthma take fewer steroid drugs while keeping attacks under control, according to clin

Population-Based Screening Can ID Children Who Progress to Clinical T1D

Population-based screening for early-stage type 1 diabetes identifies most children who progress to clinical type 1 diabetes, with additional cases detected wit